These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2127981)

  • 1. Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats.
    Sahenk Z
    Acta Neuropathol; 1990; 81(2):141-7. PubMed ID: 2127981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy.
    Sahenk Z; Mendell JR
    J Neuropathol Exp Neurol; 1979 Sep; 38(5):532-50. PubMed ID: 224150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal analysis of dithiobiuret neurotoxicity in rats and assessment of potential nonneural causes.
    Williams KD; Miller MS; Boysen BG; Peterson RE
    Toxicol Appl Pharmacol; 1987 Nov; 91(2):212-21. PubMed ID: 3118511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the paralytic agent 2,4-dithiobiuret on viability and morphology of rat pheochromocytoma (PC12) cells.
    Rheuben MB; Autio DM; Yao AZ; Atchison WD
    Neurotoxicology; 1997; 18(1):105-22. PubMed ID: 9215993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dithiobiuret neurotoxicity: an ultrastructural investigation of the lesion in preterminal axons and motor endplates in the rat lumbrical muscle.
    Jones HB
    Acta Neuropathol; 1989; 78(1):72-85. PubMed ID: 2500004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2,4-dithiobiuret treatment in rats on cholinergic function and metabolism of the extensor digitorum longus muscle.
    Weiler MH; Williams KD; Peterson RE
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):220-31. PubMed ID: 3087022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric characterization of the neuromuscular junction of rodents intoxicated with 2,4-dithiobiuret: evidence that nerve terminal recycling processes contribute to muscle weakness.
    Rheuben MB; Autio DM; Xu YF; Atchison WD
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):266-86. PubMed ID: 15081273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse.
    Oda K; Yamazaki K; Miura H; Shibasaki H; Kikuchi T
    Neuropathol Appl Neurobiol; 1992 Jun; 18(3):265-81. PubMed ID: 1630580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord.
    Lehning EJ; Balaban CD; Ross JF; LoPachi RM
    Neurotoxicology; 2002 Sep; 23(3):415-29. PubMed ID: 12387367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced safety factor for neuromuscular transmission and abnormal quantal secretion precede neuromuscular weakness induced by dithiobiuret.
    Atchison WD
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):234-44. PubMed ID: 2175053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and electrophysiological study of distal motor nerve fiber degeneration and sprouting after irreversible cholinesterase inhibition.
    Kawabuchi M; Cintra WM; Deshpande SS; Albuquerque EX
    Synapse; 1991 Jul; 8(3):218-28. PubMed ID: 1948671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vacor neuropathy: ultrastructural and axonal transport studies.
    Watson DF; Griffin JW
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):96-108. PubMed ID: 2432196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 2,4-dithiobiuret on sensory and motor function.
    Crofton KM; Dean KF; Hamrick RC; Boyes WK
    Fundam Appl Toxicol; 1991 Apr; 16(3):469-81. PubMed ID: 1906822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dithiobiuret intoxication on motor end plates in sternocostalis and hindlimb muscles of female rats.
    Kemplay S
    Acta Neuropathol; 1984; 65(1):77-84. PubMed ID: 6440404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute alterations in murine neuromuscular transmission following exposure to a nonparalytic dose of dithiobiuret.
    Spitsbergen JM; Atchison WD
    Toxicol Appl Pharmacol; 1990 Jan; 102(1):68-79. PubMed ID: 2153319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: effects of acetyl-L-carnitine.
    Fernandez E; Pallini R; Gangitano C; Del Fa A; Olivieri-Sangiacomo C; Sbriccoli A; Ricoy J; Rossi GF
    Int J Clin Pharmacol Res; 1990; 10(1-2):85-99. PubMed ID: 2387666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.